Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
03/04/2009 | CN101379077A Small peptidic and peptido-mimetic affinity ligands for factor VIII and factor VIII-like proteins |
03/04/2009 | CN101379075A Synthesis of glucagon-like peptide |
03/03/2009 | US7498404 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
03/03/2009 | US7498403 Peptides capable of binding to titanium silver silicone |
03/03/2009 | US7498310 Applying a water in oil emulsion of a tetrapeptide: H2N-Valine-Valine-Arginine-Proline or one of its amide derivatives |
03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
03/03/2009 | US7498162 A gene expressed polypeptide is used in food, for treating food allergy |
03/03/2009 | US7498138 Multimerization of HIV-1 Vif protein as a therapeutic target |
03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
03/03/2009 | US7498025 Targeted bifunctional molecules and therapies based thereon |
03/03/2009 | US7498021 Peptide that binds to integrins |
03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
02/26/2009 | WO2009026233A2 Self assembling peptide systems and methods |
02/26/2009 | WO2009026218A2 Identification and use of peptide inhibitors of protein synthesis |
02/26/2009 | WO2009026155A2 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
02/26/2009 | WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same |
02/26/2009 | WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same |
02/26/2009 | WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same |
02/26/2009 | WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer |
02/26/2009 | WO2009024571A1 Blood coagulation factor inhibitors |
02/26/2009 | WO2009024528A1 Use of cyclic depsipeptides to inhibit kallikrein 7 |
02/26/2009 | WO2009024070A1 Detection and quantitation of urine gelsolin |
02/26/2009 | WO2009006638A3 Peptides facilitating retrograde transport and their uses |
02/26/2009 | WO2008109653A3 Peptides specific for human blood outgrowth endothelial cells |
02/26/2009 | WO2008099285A3 Control of transport properties to and from nanoparticle surfaces |
02/26/2009 | US20090055975 Plant virus transmission inhibitor and methods |
02/26/2009 | US20090054349 Peptides for Promoting Hair Growth and Improving Wrinkle and Cosmetic Compositions Comprising the same |
02/26/2009 | US20090054348 Bi-dentate compounds as kinase inhibitors |
02/26/2009 | US20090054347 Kinin b1 receptor peptide agonists and uses thereof |
02/26/2009 | US20090054345 Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity |
02/26/2009 | US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof |
02/26/2009 | US20090054342 Bioactive peptides and method of using same |
02/26/2009 | US20090054333 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
02/26/2009 | US20090054332 Thombopoietin peptide conjugates |
02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
02/26/2009 | US20090054317 Polyvalent inhibitors of pathogens |
02/26/2009 | US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
02/26/2009 | US20090054309 Peptidic vasopressin receptor agonists |
02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
02/26/2009 | US20090053750 Methods and compositions for identifying a cellular immune response against prostate cancer |
02/26/2009 | US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) |
02/26/2009 | US20090053257 Replikin peptides and uses thereof |
02/26/2009 | US20090053202 Peptide fragment of LYVE-1 and antibody against the same |
02/26/2009 | US20090053151 Antibacterial peptides and analogues thereof |
02/26/2009 | DE112007001030T5 Amyloid-ß-Fibrillogenese-inhibierendes Peptid Amyloid-beta fibrillogenesis-inhibiting peptide |
02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
02/26/2009 | CA2696597A1 Foxm1 peptide and medicinal agent comprising the same |
02/26/2009 | CA2696591A1 Cdh3 peptide and medicinal agent comprising the same |
02/25/2009 | EP2028191A1 Peptides and compounds that bind to a receptor |
02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
02/25/2009 | EP1471920B1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
02/25/2009 | EP1247532B1 Composition promoting lacrimal secretion |
02/25/2009 | CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
02/25/2009 | CN101374857A Novel T-helper antigenic determinant (THD) peptides |
02/25/2009 | CN101374856A Inhibiting tumor cell invasion, metastasis and angiogenesis |
02/25/2009 | CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
02/25/2009 | CN101372508A Polypeptide and use thereof |
02/25/2009 | CN101372507A Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof |
02/25/2009 | CN101372506A Novel process for preparing eptifibatide by purification |
02/25/2009 | CN101372505A Method for preparing desmopressin acetate |
02/25/2009 | CN101372504A Method for purifying desmopressin |
02/24/2009 | US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
02/24/2009 | US7494980 administering a decapeptide of the sequence NH2-Iys-lys-val-val-phe-lys-val-lys-phe-lys-CONH2; biofilm formation inhibition; anticaries agent |
02/24/2009 | US7494979 Method for treating congestive heart failure and other disorders |
02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
02/24/2009 | US7494767 Assay for TSG101 as inhibitors of HIV production |
02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
02/24/2009 | CA2324380C Assay for the diagnosis of schizophrenia based on a new peptide |
02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
02/19/2009 | WO2009023306A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
02/19/2009 | WO2009022652A1 Lck-derived peptide useful for cancer vaccine therapy on cancer patient who is positive for hla-a3 supertype allele |
02/19/2009 | WO2009022339A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
02/19/2009 | WO2009022154A2 Peptide with multiple epitopes |
02/19/2009 | WO2008152252A3 Rumc peptides with antimicrobial activity |
02/19/2009 | WO2008142319A3 Peptide analogues of melanocortin receptors |
02/19/2009 | WO2008133908A3 Suspension formulations of insulinotropic peptides and uses thereof |
02/19/2009 | US20090048428 inclusion body tags; Expression of the fusion peptide in a host cell results in a product that is insoluble and contained within inclusion bodies in the cell and/or cell lysate |
02/19/2009 | US20090048180 Sustained-release preparation |
02/19/2009 | US20090048178 Lps or lipid a binding agent and novel peptide |
02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
02/19/2009 | US20090048171 Treatment of viral infections |
02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
02/19/2009 | US20090048168 Inhibitors of bcl-2 |
02/19/2009 | US20090048166 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
02/19/2009 | US20090048147 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
02/19/2009 | US20090047654 Polymer affinity matrix, a method for the production and use thereof |
02/19/2009 | US20090047360 Bone morphogenic protein binding peptide |
02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
02/19/2009 | CA2695971A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
02/19/2009 | CA2687024A1 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
02/18/2009 | EP2024389A2 Imaging agent |